Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Tongil Hospital Tongji Medical College Huazhong University Of Science And Technology is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being reviewed by 1 distinct examiner within a single distinct art unit, indicating a singular focus for their current filings. This narrow distribution suggests that the hospital is currently focusing its intellectual property efforts on a specific biotechnological or pharmaceutical invention.
The busiest examiner, PAULUS, ERIN VIRGINIA, is responsible for the pending action. Because there is only the 1 pending office action in the portfolio, the hospital's current prosecution success depends on navigating the specific requirements of this examiner and art unit. Practitioners should focus on the history and preferences of the assigned examiner, as there are no other pending office actions to provide a broader view of the hospital's prospects in the Biotechnology & Pharmaceuticals sector. The outcome of this single matter will be the sole determinant of the hospital's near-term progress in securing new patent rights.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAULUS, ERIN VIRGINIA | 1 | 20.0% | +94.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18426681 | A shRNA, its recombinant expression vector, transformant, anti-heart failure drug, preparation method, and use as drug thereof | PAULUS, ERIN VIRGINIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18426681 | A shRNA, its recombinant expression vector, transformant, anti-heart failure drug, preparation method, and use as drug thereof | PAULUS, ERIN VIRGINIA | — |
| Art Unit | Apps |
|---|---|
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18426681 | A shRNA, its recombinant expression vector, transformant, anti-heart failure drug, preparation method, and use as drug thereof | PAULUS, ERIN VIRGINIA | 1631 | §112 | Non-Final OA | — | Pending | Jan 30, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTongil Hospital Tongji Medical College Huazhong University Of Science And Technology has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Erin Virginia Paulus has the most, with 1 of Tongil Hospital Tongji Medical College Huazhong University Of Science And Technology's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
